Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors

Bioorg Med Chem. 2009 Nov 1;17(21):7531-6. doi: 10.1016/j.bmc.2009.09.018. Epub 2009 Sep 15.

Abstract

Fourteen metronidazole derivatives (compounds 3a-f and 4b-h) have been synthesized by coupling of metronidazole and salicylic acid derivatives. All of them are reported for the first time. Their chemical structures are characterized by (1)H NMR, MS, and elemental analysis. The inhibitory activities against Helicobacter pylori urease have been investigated in vitro and many compounds have showed promising potential inhibitory activities of H. pylori urease. The effect of compounds 4b (IC(50)=26 microM) and 4 g (IC(50)=12 microM) was comparable with that of acetohydroxamic acid, a well known H. pylori urease inhibitor used as a positive control. The experimental values of IC(50) showed that inhibitor was potent urease inhibitor. A docking analysis using the autodock 4.0 program could explain the inhibitory activities of compound 4 g against H. pylori urease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / chemical synthesis*
  • Anti-Infective Agents / chemistry
  • Anti-Infective Agents / pharmacology
  • Binding Sites
  • Catalytic Domain
  • Computer Simulation
  • Helicobacter pylori / enzymology*
  • Metronidazole / analogs & derivatives*
  • Metronidazole / chemical synthesis*
  • Metronidazole / chemistry
  • Metronidazole / pharmacology
  • Urease / antagonists & inhibitors*
  • Urease / metabolism

Substances

  • (2-methyl-5-nitro-1H-imidazol-1-yl)ethyl4-methyl-2-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)benzoate
  • (2-methyl-5-nitro-1H-imidazol-1-yl)ethyl5-bromo-2-(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy)benzoate
  • Anti-Infective Agents
  • Metronidazole
  • Urease